NASDAQ: AZRX
SEARCH
SIGN UP
About
Back
Company Profile
Management Team
Board of Directors
Scientific Advisory Board
Science & Technology
Back
Products
Back
MS-1819
FW-420
FW-1022
Programs
Back
Pipeline
Clinical Trials
Indications
Back
EPI in Cystic Fibrosis
Checkpoint Inhibitor Colitis
COVID-19 GI Infection
Investors
Back
Press Releases
Back
2021
2020
2019
2018
2017
2016
2015
2014
Events
Presentations
Regulatory Filings
Financial Statements
Stock Info
Analyst Coverage
Corporate Governance
Contact Us
News & Publications
Back
Press Releases
Interviews
Back
2021
2020
Clinical Publications
Contact
Back
Contact Us
Subscribe
Partnering
facebook
twitter
linkedin
youtube
Home
Investors
Press Releases
2014
Menu
Press Releases
2021
2020
2019
2018
2017
2016
2015
2014
Events
Presentations
Regulatory Filings
Financial Statements
Stock Info
Analyst Coverage
Corporate Governance
Contact Us
2014 News
Filters
Title Filter
Filter
List of articles in category 2014 News
Title
Date
AzurRx Announces Issuance of U.S. Patent for its MS1819 lipase compound
31 Jul, 2014
